Cervical Cancer Epidemiology, Prevention and Screening among Women Living with HIV in the Americas region: A Systematic Review Protocol A Systematic Review Protocol
Publicado
Oct 28, 2020
Almetrics
Dimensions
Google Scholar
María Caicedo-Martínez, MD
http://orcid.org/0000-0001-5799-2096
Camila Ordóñez-Reyes, MD
http://orcid.org/0000-0002-8941-9064
Ginna Fernández-Deaza, MD
http://orcid.org/0000-0002-0080-4071
Raúl Murillo, MD, MPH
http://orcid.org/0000-0001-7187-9946
Maeve B Mello, BSc, PhD
http://orcid.org/0000-0002-2573-7776
Bernardo Nuche-Berenguer, MPH, PHD
http://orcid.org/0000-0001-8694-574X
http://orcid.org/0000-0001-5799-2096
Camila Ordóñez-Reyes, MD
http://orcid.org/0000-0002-8941-9064
Ginna Fernández-Deaza, MD
http://orcid.org/0000-0002-0080-4071
Raúl Murillo, MD, MPH
http://orcid.org/0000-0001-7187-9946
Maeve B Mello, BSc, PhD
http://orcid.org/0000-0002-2573-7776
Bernardo Nuche-Berenguer, MPH, PHD
http://orcid.org/0000-0001-8694-574X
##plugins.themes.bootstrap3.article.details##
Resumo
Background: Women living with HIV (WLHIV) are more prone to persistent infection with high-risk Human Papillomavirus (HR-HPV) and development of cervical pre-cancer and cancer. Health systems should integrate HPV and HIV services considering particularities of WLHIV when offering comprehensive cervical cancer services. Objectives: To synthesize existing knowledge on cervical cancer epidemiology, as well as access to screening and prevention among women living with HIV in the Americas Region. Methods: Nine PICO questions will orient a systematic review of published literature in Medline and LILACS; supplemented with cross-referencing and search of grey literature in Trip and Google-Scholar. The protocol will follow PRISMA-P standards. Two reviewers will screen titles and abstracts independently; disagreements will be solved by consensus. Verification of eligibility based on full-text reading will be carried out. Studies finally included will be assessed for risk of bias based on standard tools by type of study. Data extraction tables will be built for every PICO question and reported in a structured format. A meta-analysis will be performed depending upon the results. Discussion: This systematic review anticipates finding valuable information for policy makers and public health actors as it aims to provide new data on a special population from the Americas region.
Keywords
References
1. International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. [Internet]. Available from: https://gco.iarc.fr/
2. World Health Organization. Draft: Global Strategy Towards the Elimination of Cervical Cancer as a Public Health Program. [Internet]. 2019. Available from: https://www.who.int/docs/default-source/documents/cervical-cancer-elimination-draft-strategy.pdf?sfvrsn=380979d6_4
3. UNAIDS. UNAIDS DATA 2019. In 2019. Available from: https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf
4. Abraham AG, D’Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study. JAIDS J Acquir Immune Defic Syndr. 2013 Apr;62(4):405–13.
5. Mohammed D, Shukla P, Babayants Y, Sison R, Slim J. Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016. Int J Womens Health. 2018 Feb;Volume 10:83–7.
6. Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer: AIDS. 2018 Mar;32(6):795–808.
7. Denslow SA, Rositch AF, Firnhaber C, Ting J, JS Smith. Incidence and progression of cervical lesions in women with HIV: A systematic global review. Int J STD AIDS. 2014 Mar;25(3):163–77.
8. Weldegebreal F, Worku T. Precancerous Cervical Lesion Among HIV-Positive Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. SAGE. 2019;26:1–11.
9. Clifford GM, Goncalves MAG, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS. 2006;20:2337–44.
10. Cervical cancer risk in women living with HIV across four continents: A multicohort study - Rohner - 2020 - International Journal of Cancer - Wiley Online Library [Internet]. [cited 2020 Jan 20]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32260
11. Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis. 2017 May 1;64(9):1228–35.
12. PAHO. Pan American Health Orgnization: Member States [Internet]. [cited 2020 Jan 22]. Available from: https://www.paho.org/hq/index.php?option=com_content&view=article&id=103:member-states&Itemid=1110&lang=fr
13. Pan American Health Organization. Plan of Action for the prevention and control of HIV and sexually transmitted infections 2016-2021. WHO; 2016.
14. Pan American Health Organization. PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL 2018-2030. [Internet]. PAHO; 2018. Available from: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=mandates-strategies-3448&alias=47584-plan-cervical-cancer-2018-2030&Itemid=270&lang=en
15. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009 Dec 4;339(jul21 1):b2700–b2700.
16. Universal health coverage and universal access. - PubMed - NCBI [Internet]. [cited 2020 Jan 20]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23940398
17. BMJ OPEN. Appraisal tool for Cross-Sectional Studies (AXIS).
18. Guyatt G, Rennie D, Meade M, Cook D, American Medical Association, editors. Users’ guides to the medical literature. A manual for evidence-based clinical practice. Third edition. New York: McGraw-Hill Education Medical; 2015. (JAMAevidence).
19. Lockwood C, et al. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. International Journal of Evidence-Based Healthcare. 2015;13:179–87.
20. Ofman J, Sullivan S, Neumann P, Chiun-Fang C, Henning J, Wade S, et al. Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES. J Managed Care Pharm. 2003;9(1):53–61.
21. Kelly H, Weiss HA, Benavente Y, de Sanjose Silvia, Mayaud Philippe. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2017 Oct;5:45–58.
22. Menon S, et al. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research. BMJ Open. 2017;7:e015123.
2. World Health Organization. Draft: Global Strategy Towards the Elimination of Cervical Cancer as a Public Health Program. [Internet]. 2019. Available from: https://www.who.int/docs/default-source/documents/cervical-cancer-elimination-draft-strategy.pdf?sfvrsn=380979d6_4
3. UNAIDS. UNAIDS DATA 2019. In 2019. Available from: https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf
4. Abraham AG, D’Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study. JAIDS J Acquir Immune Defic Syndr. 2013 Apr;62(4):405–13.
5. Mohammed D, Shukla P, Babayants Y, Sison R, Slim J. Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016. Int J Womens Health. 2018 Feb;Volume 10:83–7.
6. Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer: AIDS. 2018 Mar;32(6):795–808.
7. Denslow SA, Rositch AF, Firnhaber C, Ting J, JS Smith. Incidence and progression of cervical lesions in women with HIV: A systematic global review. Int J STD AIDS. 2014 Mar;25(3):163–77.
8. Weldegebreal F, Worku T. Precancerous Cervical Lesion Among HIV-Positive Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. SAGE. 2019;26:1–11.
9. Clifford GM, Goncalves MAG, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS. 2006;20:2337–44.
10. Cervical cancer risk in women living with HIV across four continents: A multicohort study - Rohner - 2020 - International Journal of Cancer - Wiley Online Library [Internet]. [cited 2020 Jan 20]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32260
11. Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis. 2017 May 1;64(9):1228–35.
12. PAHO. Pan American Health Orgnization: Member States [Internet]. [cited 2020 Jan 22]. Available from: https://www.paho.org/hq/index.php?option=com_content&view=article&id=103:member-states&Itemid=1110&lang=fr
13. Pan American Health Organization. Plan of Action for the prevention and control of HIV and sexually transmitted infections 2016-2021. WHO; 2016.
14. Pan American Health Organization. PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL 2018-2030. [Internet]. PAHO; 2018. Available from: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=mandates-strategies-3448&alias=47584-plan-cervical-cancer-2018-2030&Itemid=270&lang=en
15. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009 Dec 4;339(jul21 1):b2700–b2700.
16. Universal health coverage and universal access. - PubMed - NCBI [Internet]. [cited 2020 Jan 20]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23940398
17. BMJ OPEN. Appraisal tool for Cross-Sectional Studies (AXIS).
18. Guyatt G, Rennie D, Meade M, Cook D, American Medical Association, editors. Users’ guides to the medical literature. A manual for evidence-based clinical practice. Third edition. New York: McGraw-Hill Education Medical; 2015. (JAMAevidence).
19. Lockwood C, et al. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. International Journal of Evidence-Based Healthcare. 2015;13:179–87.
20. Ofman J, Sullivan S, Neumann P, Chiun-Fang C, Henning J, Wade S, et al. Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES. J Managed Care Pharm. 2003;9(1):53–61.
21. Kelly H, Weiss HA, Benavente Y, de Sanjose Silvia, Mayaud Philippe. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2017 Oct;5:45–58.
22. Menon S, et al. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research. BMJ Open. 2017;7:e015123.
Como Citar
Caicedo-Martínez, M., Ordóñez-Reyes, C., Fernández-Deaza, G., Murillo, R., Mello, M. B., & Nuche-Berenguer, B. (2020). Cervical Cancer Epidemiology, Prevention and Screening among Women Living with HIV in the Americas region: A Systematic Review Protocol: A Systematic Review Protocol. Universitas Medica, 61(4). https://doi.org/10.11144/Javeriana.umed61-4.ccep
Edição
Seção
Artículos originales
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.